Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.
Identifieur interne : 000053 ( Main/Exploration ); précédent : 000052; suivant : 000054Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.
Auteurs : Jennifer E. Isenor [Canada] ; Beth A. O'Reilly [Canada] ; Susan K. Bowles [Canada]Source :
- BMC public health [ 1471-2458 ] ; 2018.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Grippe humaine (), Humains, Jeune adulte, Médecins, Nourrisson, Nouvelle-Écosse, Pharmaciens, Politique de santé, Programmes de vaccination (organisation et administration), Santé publique, Sujet âgé, Vaccins antigrippaux (administration et posologie), Évaluation de programme.
- MESH :
- administration et posologie : Vaccins antigrippaux.
- organisation et administration : Programmes de vaccination.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Grippe humaine, Humains, Jeune adulte, Médecins, Nourrisson, Nouvelle-Écosse, Pharmaciens, Politique de santé, Santé publique, Sujet âgé, Évaluation de programme.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Child, Child, Preschool, Health Policy, Humans, Immunization Programs (organization & administration), Infant, Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Middle Aged, Nova Scotia, Pharmacists, Physicians, Program Evaluation, Public Health, Universal Health Insurance, Vaccination Coverage (statistics & numerical data), Young Adult.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic : Nova Scotia.
- organization & administration : Immunization Programs.
- prevention & control : Influenza, Human.
- statistics & numerical data : Vaccination Coverage.
- Adolescent, Adult, Aged, Child, Child, Preschool, Health Policy, Humans, Infant, Middle Aged, Pharmacists, Physicians, Program Evaluation, Public Health, Universal Health Insurance, Young Adult.
Abstract
BACKGROUND
Influenza is a serious public health concern, resulting in morbidity, mortality and significant expense to healthcare systems worldwide. Annual vaccination is the most effective way to prevent influenza. The National Advisory Committee on Immunization in Canada recommends that everyone six months of age and older without contraindications should be vaccinated. The Canadian province of Nova Scotia implemented a publicly-funded universal influenza vaccination program in the 2010-2011 influenza season. In 2013, pharmacists in Nova Scotia gained the authority to provide a variety of vaccinations, including the publicly-funded influenza vaccine. This study aimed to investigate any changes in influenza vaccine coverage following the implementation of each policy change: 1) universal publicly-funded program and 2) universal publicly-funded program with the addition of pharmacists.
METHODS
Influenza seasons evaluated were from 2006-2007 to 2015-2016. Coverage was estimated by examining Nova Scotia census data with aggregate immunization administration data, including the total number of vaccinations administered according to vaccine provider (physician, public health or pharmacist), geographic region, vaccine recipient age and year.
RESULTS
The analysis showed an increase in influenza vaccine coverage immediately following the implementation of the two studied policy changes. Vaccine coverage increased from 36.4 to 38% following the implementation of the universally funded vaccine policy. Following the implementation of pharmacists as immunizers, coverage increased from 35.7 to 41.7%. Vaccine coverage was highest in those 65 years of age and older during all years evaluated. Physicians provided the highest proportion of vaccines during all study periods, however a decreasing trend through all periods was observed. Physicians proportionately provided more vaccines in urban areas; whereas pharmacist and public health immunization providers in rural areas provided proportionately more vaccinations than their urban counterparts.
CONCLUSIONS
The addition of a universally funded vaccination policy and the addition of pharmacists as providers of the influenza vaccine resulted in increases in vaccine coverage initially. Additional research is needed to determine the long-term impacts of the policy changes on vaccination coverage and to identify other important factors affecting vaccine uptake.
DOI: 10.1186/s12889-018-5697-x
PubMed: 29940903
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.</title><author><name sortKey="Isenor, Jennifer E" sort="Isenor, Jennifer E" uniqKey="Isenor J" first="Jennifer E" last="Isenor">Jennifer E. Isenor</name><affiliation wicri:level="1"><nlm:affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada. jennifer.isenor@dal.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2</wicri:regionArea><wicri:noRegion>B3H 4R2</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS, Canada. jennifer.isenor@dal.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS</wicri:regionArea><wicri:noRegion>NS</wicri:noRegion></affiliation></author><author><name sortKey="O Reilly, Beth A" sort="O Reilly, Beth A" uniqKey="O Reilly B" first="Beth A" last="O'Reilly">Beth A. O'Reilly</name><affiliation wicri:level="1"><nlm:affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2</wicri:regionArea><wicri:noRegion>B3H 4R2</wicri:noRegion></affiliation></author><author><name sortKey="Bowles, Susan K" sort="Bowles, Susan K" uniqKey="Bowles S" first="Susan K" last="Bowles">Susan K. Bowles</name><affiliation wicri:level="1"><nlm:affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2</wicri:regionArea><wicri:noRegion>B3H 4R2</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS</wicri:regionArea><wicri:noRegion>NS</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Nova Scotia Health Authority, 1276 South Park Street, Halifax, NS, B3H 2Y9, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacy, Nova Scotia Health Authority, 1276 South Park Street, Halifax, NS, B3H 2Y9</wicri:regionArea><wicri:noRegion>B3H 2Y9</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29940903</idno><idno type="pmid">29940903</idno><idno type="doi">10.1186/s12889-018-5697-x</idno><idno type="wicri:Area/Main/Corpus">000041</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000041</idno><idno type="wicri:Area/Main/Curation">000041</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000041</idno><idno type="wicri:Area/Main/Exploration">000041</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.</title><author><name sortKey="Isenor, Jennifer E" sort="Isenor, Jennifer E" uniqKey="Isenor J" first="Jennifer E" last="Isenor">Jennifer E. Isenor</name><affiliation wicri:level="1"><nlm:affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada. jennifer.isenor@dal.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2</wicri:regionArea><wicri:noRegion>B3H 4R2</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS, Canada. jennifer.isenor@dal.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS</wicri:regionArea><wicri:noRegion>NS</wicri:noRegion></affiliation></author><author><name sortKey="O Reilly, Beth A" sort="O Reilly, Beth A" uniqKey="O Reilly B" first="Beth A" last="O'Reilly">Beth A. O'Reilly</name><affiliation wicri:level="1"><nlm:affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2</wicri:regionArea><wicri:noRegion>B3H 4R2</wicri:noRegion></affiliation></author><author><name sortKey="Bowles, Susan K" sort="Bowles, Susan K" uniqKey="Bowles S" first="Susan K" last="Bowles">Susan K. Bowles</name><affiliation wicri:level="1"><nlm:affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2</wicri:regionArea><wicri:noRegion>B3H 4R2</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS</wicri:regionArea><wicri:noRegion>NS</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Nova Scotia Health Authority, 1276 South Park Street, Halifax, NS, B3H 2Y9, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacy, Nova Scotia Health Authority, 1276 South Park Street, Halifax, NS, B3H 2Y9</wicri:regionArea><wicri:noRegion>B3H 2Y9</wicri:noRegion></affiliation></author></analytic><series><title level="j">BMC public health</title><idno type="eISSN">1471-2458</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Child</term><term>Child, Preschool</term><term>Health Policy</term><term>Humans</term><term>Immunization Programs (organization & administration)</term><term>Infant</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (prevention & control)</term><term>Middle Aged</term><term>Nova Scotia</term><term>Pharmacists</term><term>Physicians</term><term>Program Evaluation</term><term>Public Health</term><term>Universal Health Insurance</term><term>Vaccination Coverage (statistics & numerical data)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Grippe humaine ()</term><term>Humains</term><term>Jeune adulte</term><term>Médecins</term><term>Nourrisson</term><term>Nouvelle-Écosse</term><term>Pharmaciens</term><term>Politique de santé</term><term>Programmes de vaccination (organisation et administration)</term><term>Santé publique</term><term>Sujet âgé</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Évaluation de programme</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Nova Scotia</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Programmes de vaccination</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Immunization Programs</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination Coverage</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Child</term><term>Child, Preschool</term><term>Health Policy</term><term>Humans</term><term>Infant</term><term>Middle Aged</term><term>Pharmacists</term><term>Physicians</term><term>Program Evaluation</term><term>Public Health</term><term>Universal Health Insurance</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Grippe humaine</term><term>Humains</term><term>Jeune adulte</term><term>Médecins</term><term>Nourrisson</term><term>Nouvelle-Écosse</term><term>Pharmaciens</term><term>Politique de santé</term><term>Santé publique</term><term>Sujet âgé</term><term>Évaluation de programme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Influenza is a serious public health concern, resulting in morbidity, mortality and significant expense to healthcare systems worldwide. Annual vaccination is the most effective way to prevent influenza. The National Advisory Committee on Immunization in Canada recommends that everyone six months of age and older without contraindications should be vaccinated. The Canadian province of Nova Scotia implemented a publicly-funded universal influenza vaccination program in the 2010-2011 influenza season. In 2013, pharmacists in Nova Scotia gained the authority to provide a variety of vaccinations, including the publicly-funded influenza vaccine. This study aimed to investigate any changes in influenza vaccine coverage following the implementation of each policy change: 1) universal publicly-funded program and 2) universal publicly-funded program with the addition of pharmacists.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Influenza seasons evaluated were from 2006-2007 to 2015-2016. Coverage was estimated by examining Nova Scotia census data with aggregate immunization administration data, including the total number of vaccinations administered according to vaccine provider (physician, public health or pharmacist), geographic region, vaccine recipient age and year.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>The analysis showed an increase in influenza vaccine coverage immediately following the implementation of the two studied policy changes. Vaccine coverage increased from 36.4 to 38% following the implementation of the universally funded vaccine policy. Following the implementation of pharmacists as immunizers, coverage increased from 35.7 to 41.7%. Vaccine coverage was highest in those 65 years of age and older during all years evaluated. Physicians provided the highest proportion of vaccines during all study periods, however a decreasing trend through all periods was observed. Physicians proportionately provided more vaccines in urban areas; whereas pharmacist and public health immunization providers in rural areas provided proportionately more vaccinations than their urban counterparts.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>The addition of a universally funded vaccination policy and the addition of pharmacists as providers of the influenza vaccine resulted in increases in vaccine coverage initially. Additional research is needed to determine the long-term impacts of the policy changes on vaccination coverage and to identify other important factors affecting vaccine uptake.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29940903</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>06</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.</ArticleTitle><Pagination><MedlinePgn>787</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-018-5697-x</ELocationID><Abstract><AbstractText Label="BACKGROUND">Influenza is a serious public health concern, resulting in morbidity, mortality and significant expense to healthcare systems worldwide. Annual vaccination is the most effective way to prevent influenza. The National Advisory Committee on Immunization in Canada recommends that everyone six months of age and older without contraindications should be vaccinated. The Canadian province of Nova Scotia implemented a publicly-funded universal influenza vaccination program in the 2010-2011 influenza season. In 2013, pharmacists in Nova Scotia gained the authority to provide a variety of vaccinations, including the publicly-funded influenza vaccine. This study aimed to investigate any changes in influenza vaccine coverage following the implementation of each policy change: 1) universal publicly-funded program and 2) universal publicly-funded program with the addition of pharmacists.</AbstractText><AbstractText Label="METHODS">Influenza seasons evaluated were from 2006-2007 to 2015-2016. Coverage was estimated by examining Nova Scotia census data with aggregate immunization administration data, including the total number of vaccinations administered according to vaccine provider (physician, public health or pharmacist), geographic region, vaccine recipient age and year.</AbstractText><AbstractText Label="RESULTS">The analysis showed an increase in influenza vaccine coverage immediately following the implementation of the two studied policy changes. Vaccine coverage increased from 36.4 to 38% following the implementation of the universally funded vaccine policy. Following the implementation of pharmacists as immunizers, coverage increased from 35.7 to 41.7%. Vaccine coverage was highest in those 65 years of age and older during all years evaluated. Physicians provided the highest proportion of vaccines during all study periods, however a decreasing trend through all periods was observed. Physicians proportionately provided more vaccines in urban areas; whereas pharmacist and public health immunization providers in rural areas provided proportionately more vaccinations than their urban counterparts.</AbstractText><AbstractText Label="CONCLUSIONS">The addition of a universally funded vaccination policy and the addition of pharmacists as providers of the influenza vaccine resulted in increases in vaccine coverage initially. Additional research is needed to determine the long-term impacts of the policy changes on vaccination coverage and to identify other important factors affecting vaccine uptake.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Isenor</LastName><ForeName>Jennifer E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-1648-7362</Identifier><AffiliationInfo><Affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada. jennifer.isenor@dal.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS, Canada. jennifer.isenor@dal.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Reilly</LastName><ForeName>Beth A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowles</LastName><ForeName>Susan K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Faculty of Health, Dalhousie University, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Center for Vaccinology, Nova Scotia Health Authority, IWK Health Centre, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Nova Scotia Health Authority, 1276 South Park Street, Halifax, NS, B3H 2Y9, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Not Applicable</GrantID><Agency>Dalhousie Pharmacy Endowment Fund</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009674" MajorTopicYN="N" Type="Geographic">Nova Scotia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010595" MajorTopicYN="N">Pharmacists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019472" MajorTopicYN="N">Universal Health Insurance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Canada</Keyword><Keyword MajorTopicYN="Y">Influenza</Keyword><Keyword MajorTopicYN="Y">Pharmacist immunizers</Keyword><Keyword MajorTopicYN="Y">Physician immunizers</Keyword><Keyword MajorTopicYN="Y">Policy</Keyword><Keyword MajorTopicYN="Y">Public health</Keyword><Keyword MajorTopicYN="Y">Vaccination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29940903</ArticleId><ArticleId IdType="doi">10.1186/s12889-018-5697-x</ArticleId><ArticleId IdType="pii">10.1186/s12889-018-5697-x</ArticleId><ArticleId IdType="pmc">PMC6019522</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Ther. 2017 Aug;39(8):1563-1580.e17</Citation><ArticleIdList><ArticleId IdType="pubmed">28781217</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Jan 26;12(1):e0170550</Citation><ArticleIdList><ArticleId IdType="pubmed">28125629</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):67-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22257618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2005 Sep;39(9):1527-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16014374</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 2001 Apr;39(4):340-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11329521</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Nov 11;34(47):5708-5723</Citation><ArticleIdList><ArticleId IdType="pubmed">27765379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2012 Jun;129(6):e1421-30</Citation><ArticleIdList><ArticleId IdType="pubmed">22585770</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2016 Apr 21;21(16):</Citation><ArticleIdList><ArticleId IdType="pubmed">27123691</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2004 Feb 25;22(8):1001-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15161077</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Pharm J (Ott). 2014 Jan;147(1):33-44</Citation><ArticleIdList><ArticleId IdType="pubmed">24494014</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2005 Nov;20(11):1057-62</Citation><ArticleIdList><ArticleId IdType="pubmed">16307634</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Jan 2;31(2):279-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23174197</ArticleId></ArticleIdList></Reference><Reference><Citation>J Fam Pract. 2007 Feb;56(2 Suppl Vaccines):S61-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17270112</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2015 Jul 07;15:618</Citation><ArticleIdList><ArticleId IdType="pubmed">26148480</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Equity Health. 2016 Mar 08;15:45</Citation><ArticleIdList><ArticleId IdType="pubmed">26956154</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pharm. 2016 Apr;38(2):218-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26821372</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2005 May 20;23(27):3604-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15855020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2016 May 3;12(5):1225-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26863888</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Health Serv Res. 2014 Jan 24;14:35</Citation><ArticleIdList><ArticleId IdType="pubmed">24456532</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Pharm Assoc (2003). 2008 Mar-Apr;48(2):312-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18359736</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Rep. 2006 May;17(2):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16716034</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2017 Oct 13;35(43):5890-5896</Citation><ArticleIdList><ArticleId IdType="pubmed">28890192</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Pharm Pract. 2013 Dec;21(6):362-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23581450</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharm Policy Pract. 2016 Oct 19;9:32</Citation><ArticleIdList><ArticleId IdType="pubmed">27777781</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacotherapy. 2001 Sep;21(9):1115-22</Citation><ArticleIdList><ArticleId IdType="pubmed">11560201</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Isenor, Jennifer E" sort="Isenor, Jennifer E" uniqKey="Isenor J" first="Jennifer E" last="Isenor">Jennifer E. Isenor</name></noRegion><name sortKey="Bowles, Susan K" sort="Bowles, Susan K" uniqKey="Bowles S" first="Susan K" last="Bowles">Susan K. Bowles</name><name sortKey="Bowles, Susan K" sort="Bowles, Susan K" uniqKey="Bowles S" first="Susan K" last="Bowles">Susan K. Bowles</name><name sortKey="Bowles, Susan K" sort="Bowles, Susan K" uniqKey="Bowles S" first="Susan K" last="Bowles">Susan K. Bowles</name><name sortKey="Isenor, Jennifer E" sort="Isenor, Jennifer E" uniqKey="Isenor J" first="Jennifer E" last="Isenor">Jennifer E. Isenor</name><name sortKey="O Reilly, Beth A" sort="O Reilly, Beth A" uniqKey="O Reilly B" first="Beth A" last="O'Reilly">Beth A. O'Reilly</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000053 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000053 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:29940903
|texte= Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:29940903" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |